Study #2021-0657
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To evaluate the efficacy and safety of Scrambler therapy (ST) for chemotherapy-induced painful peripheral neuropathy (CIPN), and the impact of ST on physical functioning and quality of life (QoL) in adolescents and young adults (AYA) cancer patients. In this proposed study, we will conduct a two-arm prospective, randomized wait-list controlled clinical trial to investigate the effectiveness of ST on pain and CIPN in AYAs with cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Peripheral Neuropathy
Study phase:
Not applicable
Physician name:
Salahadin Abdi
Department:
Pain Medicine
For general questions about clinical trials:
1-877-363-0789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.